The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling

Houben, Rein M. G. J., Dodd, Peter J.·2016·PLOS Medicine

DOI 10.1371/journal.pmed.1002152

Cited by (1,001)

Items 101–200 of 1,001

Aerosolization of Mycobacterium tuberculosis by Tidal Breathing
Dinkele, Ryan, Gessner, Sophia, McKerry, Andrea, Leonard, Bryan, Leukes, Juane, Seldon, Ronnett, Warner, Digby F., Wood, Robin · 2022 · American Journal of Respiratory and Critical Care Medicine
Preventive therapy for tuberculosis in rheumatological patients undergoing therapy with biological drugs
Delia Goletti, Linda Petrone, Giuseppe Ippolito, Laura Niccoli, Carlotta Nannini, Fabrizio Cantini · 2018 · Expert Review of Anti-infective Therapy
How macrophage heterogeneity affects tuberculosis disease and therapy
David G. Russell, Nelson V. Simwela, Joshua T. Mattila, JoAnne L. Flynn, Henry Charles Mwandumba, Davide Pisu · 2025 · Nature reviews. Immunology
Diagnosis of tuberculosis through breath test: A systematic review
Antonia Morita Iswari Saktiawati, David Dwi Putera, Althaf Setyawan, Yodi Mahendradhata, Tjip S. van der Werf · 2019 · EBioMedicine
Fourth-Generation QuantiFERON-TB Gold Plus: What Is the Evidence?
Arena Shafeque, Jacob Bigio, Catherine Anne Hogan, Madhukar Pai, Niaz Banaei · 2020 · Journal of Clinical Microbiology
The C-Type Lectin Receptor DC-SIGN Has an Anti-Inflammatory Role in Human M(IL-4) Macrophages in Response to Mycobacterium tuberculosis
G. Lugo-Villarino, Anthony Troegeler, L. Balboa, Claire Lastrucci, C. Duval, Ingrid Mercier, Alan Bénard, F. Capilla, T. al Saati, Renaud Poincloux et al. · 2018 · Frontiers in Immunology
Tuberculosis: past and present
Igor Ivanes, Aurelia Ustian, Constantin Iavorschi · 2024 · Bulletin of the Academy of Sciences of Moldova Medical Sciences
The Nature and Evolution of Genomic Diversity in the Mycobacterium tuberculosis Complex
Daniela Brites, Sébastien Gagneux · 2017 · Advances in experimental medicine and biology
Mycobacterium tuberculosis : Rewiring host cell signaling to promote infection
Michael D. Stutz, Michelle P. Clark, Marcel Doerflinger, Marc Pellegrini · 2017 · Journal of Leukocyte Biology
Early Clearance of Mycobacterium tuberculosis Is Associated With Increased Innate Immune Responses
Ayesha J Verrall, Marion Schneider, Bachti Alisjahbana, Lika Apriani, Arjan van Laarhoven, Valerie A. C. M. Koeken, S. van Dorp, Emira Diadani, Fitri Utama, Rachel F. Hannaway et al. · 2019 · The Journal of Infectious Diseases
The potential impact of the COVID-19 response related lockdown on TB incidence and mortality in India
Anurag Bhargava, Hemant Deepak Shewade · 2020 · Indian Journal of Tuberculosis
Mycobacteria–host interactions in human bronchiolar airway organoids
Nino Iakobachvili, Stephen Adonai Leon‐Icaza, Kèvin Knoops, Norman Sachs, Serge Mazères, Roxane Siméone, António Peixoto, Célia Bernard, M. Murris‐Espin, Julien Mazières et al. · 2021 · Molecular Microbiology
TB preventive therapy for people living with HIV: key considerations for scale-up in resource-limited settings
Ishani Pathmanathan, Sevim Ahmedov, Eric S. Pevzner, Gloria Ebelechukwu Anyalechi, Surbhi Modi, Hannah L. Kirking, Joseph S. Cavanaugh · 2018 · The International Journal of Tuberculosis and Lung Disease
The traditional use of southern African medicinal plants in the treatment of viral respiratory diseases: A review of the ethnobotany and scientific evaluations
Ian Edwin Cock, Sandy F. van Vuuren · 2020 · Journal of Ethnopharmacology
Synthesis and characterization of hydrazones and their transition metal complexes: antimicrobial, antituberculosis and antioxidant activity
Tanisha Arora, Jai Devi, Ankit Boora, Bharti Taxak, Swati Rani · 2023 · Research on Chemical Intermediates
Association of Secukinumab Treatment With Tuberculosis Reactivation in Patients With Psoriasis, Psoriatic Arthritis, or Ankylosing Spondylitis
Boni Elizabeth Elewski, John W. Baddley, Atul A. Deodhar, Marina Magrey, Phoebe A. Rich, Enrique Roberto Soriano, Jennifer Soung, Weibin Bao, Dorothy L. Keininger, Kwaku Marfo et al. · 2020 · JAMA Dermatology
Population aging and trends of pulmonary tuberculosis incidence in the elderly
Shi-jin Li, Yi-fan Li, Wan-mei Song, Qian-yun Zhang, Si-qi Liu, Tingting Xu, Qi-qi An, Jinyue Liu, Huaichen Li · 2021 · BMC Infectious Diseases
Isoniazid-Rifapentine for Latent Tuberculosis Infection: A Systematic Review and Meta-analysis
Gibril J. Njie, Sapna Bamrah Morris, Rachel Yelk Woodruff, Ruth N. Moro, Andrew A. Vernon, Andrey S. Borisov · 2018 · American Journal of Preventive Medicine
An essential bifunctional enzyme in Mycobacterium tuberculosis for itaconate dissimilation and leucine catabolism
Hua Wang, Alexander A. Fedorov, E.V. Fedorov, Debbie M. Hunt, Angela Rodgers, Holly L. Douglas, Acely Garza-Garcı́a, J.B. Bonanno, Steven C. Almo, Luiz Pedro S. de Carvalho · 2019 · Proceedings of the National Academy of Sciences
Essential Components of a Public Health Tuberculosis Prevention, Control, and Elimination Program: Recommendations of the Advisory Council for the Elimination of Tuberculosis and the National Tuberculosis Controllers Association
Barbara Cole, Diana M. Nilsen, Lorna Will, Sue C. Etkind, Marcos V. Burgos, Terence L. Chorba · 2020 · MMWR Recommendations and Reports
The burden of diseases and risk factors in Bangladesh, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
Sheikh Mohammed Shariful Islam, Riaz Uddin, Subasish Das, Syed Imran Ahmed, Sojib Bin Zaman, Sheikh Mohammad Alif, Md. Tanvir Hossen, Malabika Sarker, George Siopis, Katherine Mary Livingstone et al. · 2023 · The Lancet Global Health
Resuscitation-promoting factors are important determinants of the pathophysiology inMycobacterium tuberculosisinfection
Andrew Rosser, Cordula M. Stover, Manish Pareek, Galina V. Mukamolova · 2017 · Critical Reviews in Microbiology
Immunopathogenic overlap between COVID-19 and tuberculosis identified from transcriptomic meta-analysis and human macrophage infection
Dylan Sheerin, Abhimanyu Abhimanyu, Nashied Peton, William Vo, Cody C. Allison, Xutao Wang, William Evan Johnson, Anna K. Coussens · 2022 · iScience
Tuberculosis in the elderly: Why inflammation matters
Tucker J. Piergallini, Joanne Turner · 2017 · Experimental Gerontology
Cutaneous tuberculosis. Part I: Pathogenesis, classification, and clinical features
Subuhi Kaul, Ishmeet Kaur, Shilpa Mehta, Archana Singal · 2022 · Journal of the American Academy of Dermatology
Diagnosis and management of latent tuberculosis infection in Asia: Review of current status and challenges
Nicholas Iain Paton, Laurence Borand, Jubert Benedicto, Mar Mar Kyi, Asif Mahmud, Mohd Nor Norazmi, Nandini Sharma, Charoen Chuchottaworn, Yi-Wen Huang, Nastiti Kaswandani et al. · 2019 · International Journal of Infectious Diseases
A review of computational and mathematical modeling contributions to our understanding of Mycobacterium tuberculosis within-host infection and treatment
Denise E. Kirschner, Elsje Pienaar, Simeone Marino, Jennifer J. Linderman · 2017 · Current Opinion in Systems Biology
Symptom- and chest-radiography screening for active pulmonary tuberculosis in HIV-negative adults and adults with unknown HIV status
Anna H. van’t Hoog, Kerri Viney, Olivia Biermann, Bada Yang, Mariska Leeflang, Miranda W. Langendam · 2022 · Cochrane Database of Systematic Reviews
Risk of Tuberculosis in Patients With Inflammatory Bowel Disease on Infliximab or Adalimumab Is Dependent on the Local Disease Burden of Tuberculosis: A Systematic Review and Meta-Analysis
Saurabh Kedia, Venigalla Pratap Mouli, Nagesh Kamat, Jeeva Sankar, Ashwin N. Ananthakrishnan, Govind Kumar Makharia, Vineet Ahuja · 2020 · The American Journal of Gastroenterology
Global burden of childhood tuberculosis
Helen Elizabeth Jenkins · 2016 · Pneumonia
An allosteric switch regulates Mycobacterium tuberculosis ClpP1P2 protease function as established by cryo-EM and methyl-TROSY NMR
Siavash Vahidi, Zev A. Ripstein, Jordan B. Juravsky, Enrico Rennella, Alfred Lewis Goldberg, Anthony Mittermaier, John L. Rubinstein, Lewis E. Kay · 2020 · Proceedings of the National Academy of Sciences
Self-clearance of Mycobacterium tuberculosis infection: implications for lifetime risk and population at-risk of tuberculosis disease
Jon C. Emery, Alexandra S Richards, Katie Dale, Christopher Finn McQuaid, Richard Guy White, Justin Timothy Denholm, Rein M G J Houben · 2021 · Proceedings of the Royal Society B Biological Sciences
The diagnostic performance of novel skin-based in-vivo tests for tuberculosis infection compared with purified protein derivative tuberculin skin tests and blood-based in vitro interferon-γ release assays: a systematic review and meta-analysis
Krutikov, M, Faust, L, Nikolayevskyy, V, Yohhei Hamada, Gupta, RK, Cirillo, D, Mateelli, A, Korobitsyn, A, Denkinger, CM, Rangaka, MX · 2022 · UCL Discovery (University College London)
Potential impact of tuberculosis vaccines in China, South Africa, and India
Rebecca Claire Harris, Tom Sumner, Gwenan M. Knight, Hui Zhang, Richard Guy White · 2020 · Science Translational Medicine
COVID-19 promoting the development of active tuberculosis in a patient with latent tuberculosis infection: A case report
Mohammed Khayat, Henghua Fan, Yusuf Vali · 2021 · Respiratory Medicine Case Reports
The potential role of ischaemia–reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and therapeutic implications
Douglas Bruce Kell, Etheresia Pretorius · 2022 · Biochemical Journal
Anemia in tuberculosis cases and household controls from Tanzania: Contribution of disease, coinfections, and the role of hepcidin
Jerry Hella, Colin Ivano Cercamondi, Francis Mhimbira, Mohamed Sasamalo, Nicole Ursula Stoffel, Marcel Zwahlen, Thomas Bodmer, Sébastien Gagneux, Klaus Reither, Michael Bruce Zimmermann et al. · 2018 · PLoS ONE
Long-term Stability of Resistance to Latent Mycobacterium tuberculosis Infection in Highly Exposed Tuberculosis Household Contacts in Kampala, Uganda
Catherine M. Stein, Mary Nsereko, LaShaunda L. Malone, Brenda Okware, Hussein Kisingo, Sophie Nalukwago, Keith A. Chervenak, Harriet Mayanja‐Kizza, Thomas R. Hawn, W. Henry Boom · 2018 · Clinical Infectious Diseases
Management of latent tuberculosis infection in China: Exploring solutions suitable for high-burden countries
Xiaojing Cui, Lei Gao, Bin Cao · 2020 · International Journal of Infectious Diseases
Screening for Latent Tuberculosis Infection in Adults
Daniel E. Jonas, Sean R. Riley, Lindsey C. Lee, Cory P. Coffey, Shuhua Wang, Gary N Asher, Anne M. Berry, Niketa Williams, Casey P. Balio, Christiane E. Voisin et al. · 2023 · JAMA
From immunology to artificial intelligence: revolutionizing latent tuberculosis infection diagnosis with machine learning
Linsheng Li, Ling Yang, Zhuang Li, Zhaoyang Ye, Weiguo Zhao, Wenping Gong · 2023 · Military Medical Research
Macrophage-targeted drugamers with enzyme-cleavable linkers deliver high intracellular drug dosing and sustained drug pharmacokinetics against alveolar pulmonary infections
Fang‐Yi Su, Selvi Srinivasan, Brian Lee, Jasmin Chen, Anthony J. Convertine, Timothy Eoin West, Daniel M. Ratner, Shawn J. Skerrett, Patrick S. Stayton · 2018 · Journal of Controlled Release
The Global Fight Against Tuberculosis
Charles L. Daley · 2018 · Thoracic surgery clinics/Thorac. surg. clin.
Biomarkers for tuberculosis: the case for lipoarabinomannan
Margarida Correia‐Neves, Gabrielle Fröberg, Liudmyla Korshun, Sofia Omar Viegas, Paula Vaz, N. Ramanlal, Judith Bruchfeld, Beston Hamasur, Patrick J. Brennan, Gunilla Källenius · 2019 · ERJ Open Research
Early progression to active tuberculosis is a highly heritable trait driven by 3q23 in Peruvians
Yang Luo, Sara Suliman, Samira Asgari, Tiffany Amariuta, Yuriy Baglaenko, Marta Martínez‐Bonet, Kazuyoshi Ishigaki, María Gutiérrez‐Arcelus, Roger I. Calderon, Leonid W. Lecca et al. · 2019 · Nature Communications
Diagnostic Tests for Latent Tuberculosis Infection
Michelle K. Haas, Robert Belknap · 2019 · Clinics in Chest Medicine
Mycobacterium tuberculosis-specific cytokine biomarkers to differentiate active TB and LTBI: A systematic review
Eva L. Sudbury, Vanessa Clifford, Nicole L. Messina, Rinn Song, Nigel C Curtis · 2020 · Journal of Infection
Adverse events in adults with latent tuberculosis infection receiving daily rifampicin or isoniazid: post-hoc safety analysis of two randomised controlled trials
Jonathon R. Campbell, Anete Trajman, Victoria J. Cook, James Cameron Johnston, Mênonli Adjobimey, Rovina Ruslami, Lisa Eisenbeis, Federica Fregonese, Chantal Valiquette, Andrea Benedetti et al. · 2019 · The Lancet Infectious Diseases
Contained Mycobacterium tuberculosis infection induces concomitant and heterologous protection
Johannes Nemeth, Gregory S. Olson, Alissa C. Rothchild, Ana N. Jahn, Dat Mai, Fergal J. Duffy, Jared L. Delahaye, Sanjay R Srivatsan, Courtney Ray Plumlee, Kevin B. Urdahl et al. · 2020 · PLoS Pathogens
Initiation and completion of treatment for latent tuberculosis infection in migrants globally: a systematic review and meta-analysis
Kieran Rustage, Jessica Lobe, Sally E Hayward, Kristina L Kristensen, Ioana Margineanu, Ymkje Stienstra, Delia Goletti, Dominik Zenner, Teymur Noori, Manish Pareek et al. · 2021 · The Lancet Infectious Diseases
Host-Directed Therapy as a Novel Treatment Strategy to Overcome Tuberculosis: Targeting Immune Modulation
Sultan Ahmed, Rubhana Raqib, Gudmundur Hrafn Gudmundsson, Peter Bergman, Birgitta Agerberth, Rokeya Sultana Rekha · 2020 · Antibiotics
Capsular glycan recognition provides antibody-mediated immunity against tuberculosis
Tingting Chen, Caroline Blanc, Yanyan Liu, Elise Ishida, Sarah Singer, Jiayong Xu, Maju Joe, Elizabeth R. Jenny-Avital, John Chan, Todd L. Lowary et al. · 2020 · Journal of Clinical Investigation
The monogenic basis of human tuberculosis
Stéphanie Boisson‐Dupuis · 2020 · Human Genetics
Tuberculosis elimination and the challenge of latent tuberculosis
Alberto Matteelli, Giorgia Sulis, Susanna Capone, Lia D’Ambrosio, Giovanni Battista Migliori, Haileyesus Getahun · 2017 · La Presse Médicale
The Relationship Between Latent Tuberculosis Infection and Acute Myocardial Infarction
Moises Arturo Huaman, Eduardo Ticona, Gustavo Miranda, Richard J. Kryscio, Raquel Mugruza, Ernesto Aranda, Paola L. Rondán, David M Henson, César Ticona Huaroto, Timothy R. Sterling et al. · 2017 · Clinical Infectious Diseases
Switching biologics in psoriasis - practical guidance and evidence to support
Ya‐Chu Tsai, Tsen‐Fang Tsai · 2020 · Expert Review of Clinical Pharmacology
Detection of Mycobacterium tuberculosis complex DNA in CD34-positive peripheral blood mononuclear cells of asymptomatic tuberculosis contacts: an observational study
Mulugeta Belay, Begna Tulu, Sidra Younis, David A. Jolliffe, Dawit Tayachew, Hana Manwandu, Tenagnework Abozen, Emawayish A. Tirfie, Metasebia Tegegn, Aboma Zewude et al. · 2021 · The Lancet Microbe
Optical Biosensor Based on Surface Plasmon Resonance Nanostructure for the Detection of Mycobacterium Tuberculosis Bacteria with Ultra-High Efficiency and Detection Accuracy
Malek G. Daher, Sofyan A. Taya, Abdulkarem H. M. Almawgani, Ayman Taher Hindi, İlhami Çolak, Shobhit K. Patel · 2023 · Plasmonics
Complement Component C1q as Serum Biomarker to Detect Active Tuberculosis
Rosalie Lubbers, Jayne S. Sutherland, Delia Goletti, Roelof A. de Paus, Coline H.M. van Moorsel, Marcel Veltkamp, Stefan M.T. Vestjens, Willem Jan W. Bos, Linda Petrone, Franca Del Nonno et al. · 2018 · Frontiers in Immunology
Developing WHO guidelines: Time to formally include evidence from mathematical modelling studies
Matthias Egger, Leigh Francis Johnson, Christian Lorenz Althaus, Anna Schöni, Georgia Salanti, Nicola N Low, Susan L. Norris · 2017 · F1000Research
A point-of-need enzyme linked aptamer assay for Mycobacterium tuberculosis detection using a smartphone
Lei Li, Zhonggang Liu, Heng Zhang, Wanqing Yue, Cheuk‐Wing Li, Changqing Yi · 2017 · Sensors and Actuators B Chemical
MR1-Independent Activation of Human Mucosal-Associated Invariant T Cells by Mycobacteria
Sara Suliman, Melissa Murphy, Munyaradzi Musvosvi, Anele Gela, Erin W. Meermeier, Hennie D. Geldenhuys, Christiaan Hopley, Asma Toefy, Nicole Bilek, Ashley Veldsman et al. · 2019 · The Journal of Immunology
BCG vaccination strategies against tuberculosis: updates and perspectives
Mengjin Qu, Xiangmei Zhou, Hao Li · 2021 · Human Vaccines & Immunotherapeutics
Guidelines for the treatment of latent tuberculosis infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020
Timothy R. Sterling, Gibril J. Njie, Dominik Zenner, David L. Cohn, Randall R. Reves, Amina Ismail Ahmed, Dick Menzies, Charles Robert Horsburgh, Charles M. Crane, Marcos V. Burgos et al. · 2020 · American Journal of Transplantation
Tuberculosis: Past, present and future of the treatment and drug discovery research
Ameya D. Bendre, Peter J. Peters, Janesh Kumar · 2021 · Current Research in Pharmacology and Drug Discovery
A comprehensive survey on investigation techniques of exhaled breath (EB) for diagnosis of diseases in human body
Nilakshi Maruti Mule, Dipti D. Patil, Mandeep Kaur · 2021 · Informatics in Medicine Unlocked
Alcohol drinking and cigarette smoking in relation to risk of active tuberculosis: prospective cohort study
Avril Zixin Soh, Cynthia Bin Eng Chee, Yee Tang Wang, Jian‐Min Yuan, Woon‐Puay Koh · 2017 · BMJ Open Respiratory Research
Comprehensive review on mechanism of action, resistance and evolution of antimycobacterial drugs
Aditi Chauhan, Manoj Kumar, Awanish Kumar, Kajal Kanchan · 2021 · Life Sciences
Treatment of Latent Tuberculosis Infection—An Update
Moises Arturo Huaman, Timothy R. Sterling · 2019 · Clinics in Chest Medicine
Association between tuberculosis in men and social network structure in Kampala, Uganda
Paige B. Miller, Sarah K Zalwango, Ronald M. Galiwango, Robert Kakaire, Juliet Nabbuye Sekandi, Lauren Steinbaum, John M. Drake, Christopher C. Whalen, Noah Kiwanuka · 2021 · BMC Infectious Diseases
Role of NF-κB during Mycobacterium tuberculosis Infection
Nicole Poladian, Davit Orujyan, William Narinyan, Armani K. Oganyan, Inesa Navasardyan, Prathosh Velpuri, Abraham Chorbajian, Vishwanath Venketaraman · 2023 · International Journal of Molecular Sciences
Immune checkpoint inhibitor use and tuberculosis: a systematic review of the literature
Jacob Peter Zaemes, Chul Kim · 2020 · European Journal of Cancer
Review article: latent tuberculosis in patients with inflammatory bowel diseases receiving immunosuppression—risks, screening, diagnosis and management
Sasha Rachel Fehily, Aysha Al‐Ani, Jonathan Abdelmalak, Clarissa A. Rentsch, Eva Zhang, Justin Timothy Denholm, Douglas Forsyth Johnson, Siew C. Ng, Vishal Sharma, David T. Rubin et al. · 2022 · Alimentary Pharmacology & Therapeutics
Working and safety profiles of JAK/STAT signaling inhibitors. Are these small molecules also smart?
Elvira Favoino, Marcella Prete, Giacomo Catacchio, Piero Ruscitti, Luca Navarini, Roberto Giacomelli, Federico Perosa · 2021 · Autoimmunity Reviews
COVID-19 and tuberculosis
Heng Yang, Shuihua Lu · 2020 · Journal of Translational Internal Medicine
Specific CD4+ T cell phenotypes associate with bacterial control in people who ‘resist’ infection with Mycobacterium tuberculosis
Meng Sun, Jolie M. Phan, Nathan Scott Kieswetter, Huang Huang, Krystle K. Q. Yu, Malisa T. Smith, Yiran E. Liu, Chuangqi Wang, Sanjana Gupta, Gerlinde Obermoser et al. · 2024 · Nature Immunology
Agents of change: The role of healthcare workers in the prevention of nosocomial and occupational tuberculosis
Ruvandhi R. Nathavitharana, Patricia Bond, Angela Dramowski, Koot Kotze, Philip A. Lederer, Ingrid Oxley, Jurgens A. Peters, Chanel Rossouw, Helene‐Mari van der Westhuizen, Bart Willems et al. · 2017 · La Presse Médicale
Systematic Review and Meta-Analysis of Sex Differences in Social Contact Patterns and Implications for Tuberculosis Transmission and Control
Katherine Chisholm Horton, Anne L. Hoey, Guillaume Béraud, Elizabeth Lucy Corbett, Richard Guy White · 2020 · Emerging infectious diseases
Are we underestimating the annual risk of infection with Mycobacterium tuberculosis in high-burden settings?
David W. Dowdy, Marcel A. Behr · 2022 · The Lancet Infectious Diseases
Natural Killer T Cells and Mucosal-Associated Invariant T Cells in Lung Infections
François Trottein, Christophe Paget · 2018 · Frontiers in Immunology
BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection
Alexander C. Schmidt, Lee Fairlie, Elizabeth Hellström, Angelique Kany Kany Luabeya, Keren Middelkoop, Kogieleum Naidoo, Gonasagrie Nair, Anele Gela, Elisa Nemes, Thomas J. Scriba et al. · 2025 · New England Journal of Medicine
Mycobacterium tuberculosis Metabolism
Gabriel T. Mashabela, Timothy J. de Wet, Digby Francis Warner · 2019 · Microbiology Spectrum
Mycobacterial infections in adults with haematological malignancies and haematopoietic stem cell transplants: guidelines from the 8th European Conference on Infections in Leukaemia.
Anne Bergeron, M. Mikulska, J. de Greef, L. Bondeelle, T. Franquet, J. Herrmann, C. Lange, I. Spriet, M. Akova, J. Donnelly et al. · 2022 · Lancet. Infectious Diseases (Print)
Effect of HIV-infection on QuantiFERON-plus accuracy in patients with active tuberculosis and latent infection
Elisa Petruccioli, Teresa Chiacchio, Assunta Navarra, Valentina Vanini, Gilda Cuzzi, Claudia Cimaglia, Luigi Ruffo Codecasa, Carmela Pinnetti, Niccolò Riccardi, Fabrizio Palmieri et al. · 2020 · Journal of Infection
Active and latent tuberculosis in refugees and asylum seekers: a systematic review and meta-analysis
Proença, Raquel, Mattos Souza, Fernanda, Lisboa Bastos, Mayara, Caetano, Rosângela, Braga, José Ueleres, Faerstein, Eduardo, Trajman, Anete · 2020 · BMC Public Health
Cost-effectiveness of Preventive Therapy for Tuberculosis With Isoniazid and Rifapentine Versus Isoniazid Alone in High-Burden Settings
Karl Johnson, Gavin Churchyard, Hojoon Sohn, David W. Dowdy · 2018 · Clinical Infectious Diseases
Using Video Technology to Increase Treatment Completion for Patients With Latent Tuberculosis Infection on 3-Month Isoniazid and Rifapentine: An Implementation Study
Chee Kin Lam, Kara McGinnis Pilote, Ashraful Haque, Joseph N. Burzynski, Christine Chuck, Michelle Macaraig · 2018 · Journal of Medical Internet Research
Short-course regimens of rifapentine plus isoniazid to treat latent tuberculosis infection in older Chinese patients: a randomised controlled study
Lei Gao, Haoran Zhang, Henan Xin, Jianmin Liu, Shouguo Pan, Xiangwei Li, Ling Guan, Fei Shen, Zisen Liu, Dakuan Wang et al. · 2018 · European Respiratory Journal
Immunometabolic Signatures Predict Risk of Progression to Active Tuberculosis and Disease Outcome
Fergal J. Duffy, January Mikolaj Weiner, Scott G. Hansen, David L. Tabb, Sara Suliman, Ethan G. Thompson, Jeroen Maertzdorf, Smitha Shankar, Gerard Tromp, Shreemanta K. Parida et al. · 2019 · Frontiers in Immunology
Global tuberculosis research and its future prospects
José Antonio Garrido-Cárdenas, C. De Lamo Sevilla, M.T. Cabezas-Fernández, Francisco Rogelio Manzano-Agugliaro, Miguel Martínez‐Lirola · 2020 · Tuberculosis
Targeting isocitrate lyase for the treatment of latent tuberculosis
Ram Prasad Bhusal, Ghader Bashiri, Brooke X. C. Kwai, Jonathan Sperry, Ivanhoe K. H. Leung · 2017 · Drug Discovery Today
Diagnostic performance of an optimized transcriptomic signature of risk of tuberculosis in cryopreserved peripheral blood mononuclear cells
Fatoumatta Darboe, Stanley Kimbung Mbandi, Ethan G. Thompson, Michelle Fisher, Miguel Rodo, Michele van Rooyen, Elizabeth Filander, Nicole Bilek, Simbarashe Mabwe, Mark Hatherill et al. · 2017 · Tuberculosis
Evaluating the potential costs and impact of digital health technologies for tuberculosis treatment support
Ntwali Placide Nsengiyumva, Benjamin Mappin-Kasirer, O. Oxlade, M. Bastos, A. Trajman, D. Falzon, K. Schwartzman · 2018 · European Respiratory Journal
Further analysis of tuberculosis in eight high-burden countries based on the Global Burden of Disease Study 2021 data
Lv, Hengliang, Wang, Longhao, Zhang, Xueli, Dang, Caixia, Liu, Feng, Zhang, Xin, Bai, Junzhu, You, Shumeng, Chen, Hui, Zhang, Wenyi et al. · 2024 · Infectious Diseases of Poverty
Prevalence and factors associated with tuberculosis infection in India
Sriram Selvaraju, Banurekha Velayutham, Raghuram Rao, Kiran Rade, Kannan Thiruvengadam, Smita Asthana, Rakesh Balachandar, Sampada Dipak Bangar, Avi Kumar Bansal, Jyothi Bhat et al. · 2023 · Journal of Infection and Public Health
The traditional use of southern African medicinal plants for the treatment of bacterial respiratory diseases: A review of the ethnobotany and scientific evaluations
Ian Edwin Cock, Sandy F. van Vuuren · 2020 · Journal of Ethnopharmacology
Tuberculosis in Adolescents and Young Adults: Emerging Data on TB Transmission and Prevention among Vulnerable Young People
Katherine M. Laycock, Leslie A. Enane, Andrew P. Steenhoff · 2021 · Tropical Medicine and Infectious Disease
Diabetes is associated with increased prevalence of latent tuberculosis infection: Findings from the National Health and Nutrition Examination Survey, 2011–2012
Marissa M. Barron, Kate M. Shaw, Kai McKeever Bullard, Mohammed Kumail Ali, Matthew James Magee · 2018 · Diabetes Research and Clinical Practice
Prevalence of and risk factors associated with latent tuberculosis in Singapore: A cross-sectional survey
Peiling Yap, Kristin Hui Xian Tan, Wei Yen Lim, Timothy Barkham, Linda Wei Lin Tan, Mark I-Cheng Chen, Yee Tang Wang, Cynthia Bin Eng Chee · 2018 · International Journal of Infectious Diseases
Serum proteomics of active tuberculosis patients and contacts reveals unique processes activated during Mycobacterium tuberculosis infection
Jesús Mateos, Olivia Estévez, África González‐Fernández, Luis Anibarro, Ángeles Pallarés, Rajko Reljić, Tufária Mussá, Cremildo Gomes-Maueia, Artur Nguilichane, Jose Manuel Gallardo et al. · 2020 · Scientific Reports